Karoly Tihanyi
Affiliations: | Semmelweis Egyetem, Hungary |
Area:
Pharmacology, BiochemistryGoogle:
"Karoly Tihanyi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kocsis P, Gyertyán I, Éles J, et al. (2014) Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 995-1000 |
| Gyertyán I, Kiss B, Sághy K, et al. (2011) Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents. Neurochemistry International. 59: 925-35 |
| Hellinger E, Bakk ML, Pócza P, et al. (2010) Drug penetration model of vinblastine-treated Caco-2 cultures. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 41: 96-106 |
| Tihanyi K, Bakk ML, Hellinger E, et al. (2010) CYP Inhibition-Mediated Drug-Drug Interactions Current Enzyme Inhibition. 6: 130-145 |
| Deák K, Takács-Novák K, Kapás M, et al. (2008) Physico-chemical characterization of a novel group of dopamine D(3)/D(2) receptor ligands, potential atypical antipsychotic agents. Journal of Pharmaceutical and Biomedical Analysis. 48: 678-84 |
| Gyertyán I, Kiss B, Gál K, et al. (2007) Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. The Journal of Pharmacology and Experimental Therapeutics. 320: 1268-78 |
| Borbás T, Benko B, Dalmadi B, et al. (2006) Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 28: 51-8 |
| Szöko E, Tábi T, Borbás T, et al. (2004) Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study. Electrophoresis. 25: 2866-75 |
| Dalmadi B, Leibinger J, Szeberényi S, et al. (2003) Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 631-6 |
| Keyvani-Amineh H, Diouri M, Tihanyi K, et al. (1996) Adenovirus Type 2 Endoprotease: Isoforms and Redox Effects Journal of General Virology. 77: 2201-2207 |